WOLVERINE ASSET MANAGEMENT LLC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 30 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$35,814,000
+11.9%
32,304,000
-5.5%
0.45%
+8.6%
Q2 2019$32,009,000
+3.5%
34,195,000
+6.2%
0.42%
-0.9%
Q1 2019$30,920,000
+19.2%
32,195,0000.0%0.42%
+35.3%
Q4 2018$25,943,000
-21.3%
32,195,000
+4.9%
0.31%
-18.5%
Q3 2018$32,945,000
+2.9%
30,695,000
+0.1%
0.38%
-7.5%
Q2 2018$32,023,000
+14.8%
30,655,000
+1.7%
0.41%
+14.7%
Q1 2018$27,888,00030,155,0000.36%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Lion Point Capital, LP 30,000,000$23,930,0003.76%
Mohican Financial Management, LLC 1,000,000$800,0003.30%
Redmile Group, LLC 25,000,000$19,989,0000.80%
SSI INVESTMENT MANAGEMENT LLC 5,000,000$3,989,0000.37%
WOLVERINE ASSET MANAGEMENT LLC 32,195,000$25,943,0000.31%
Rock Springs Capital Management LP 5,000,000$4,001,0000.19%
City Financial Investment Co Ltd 1,250,000$1,004,0000.18%
PALISADE CAPITAL MANAGEMENT, LP 4,000,000$3,221,0000.12%
CSS LLC/IL 2,000,000$1,606,0000.11%
DAFNA Capital Management LLC 250,000$201,0000.10%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders